Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery

Brack Hattler1,2, Brendan M Carr3, John Messenger2

  • 1Rocky Mountain Regional VA Medical Center, Aurora, CO (B.H., F.L.G.).

Insights

One year after coronary artery bypass grafting (CABG), patient-reported angina is linked to younger age, worse baseline scores, smoking, diabetes, and depression. Incomplete revascularization of the left anterior descending (LAD) artery was the only angiographic factor associated with persistent angina.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Patient-Reported Outcomes

Background:

  • Limited studies explore the link between patient-reported angina and angiographic findings post-coronary artery bypass grafting (CABG).
  • This study investigates clinical and angiographic predictors of persistent angina symptoms one year after CABG.

Purpose of the Study:

  • To identify clinical characteristics and angiographic findings associated with self-reported angina symptoms one year after CABG.
  • To inform patient counseling and decisions regarding post-CABG coronary angiography.

Main Methods:

  • Prospective observational cohort study nested within the ROOBY trial (n=1258).
  • Utilized Seattle Angina Questionnaire (SAQ) for angina assessment and coronary angiography at one year post-CABG.
  • Multivariable modeling identified predictors of angina frequency.

Main Results:

  • Younger age, worse baseline SAQ angina frequency, smoking, diabetes mellitus, and pre-CABG depression were associated with post-CABG angina.
  • Incomplete revascularization of the left anterior descending (LAD) territory was the sole angiographic correlate of angina.
  • A significant portion of patients with angina (69.4%) did not have severe (≥70%) residual coronary stenosis.

Conclusions:

  • Patient-reported angina one year after CABG is influenced by specific clinical factors and incomplete LAD revascularization.
  • Findings may aid physicians in managing patient expectations and guiding further investigations.
  • Further research is needed to determine if treating comorbidities improves post-CABG angina.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
352
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
218
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
944
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
401
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
232
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
398